Friday, December 20, 2024

Fw: Ref.: (LML) Lepromatous leprosy – treat lifelong!

 

Leprosy Mailing List, December 20, 2024 

 

Ref.:  (LML) Lepromatous leprosy – treat lifelong!

From:  Ben Naafs, Munnekeburen, the Netherlands

 


 

 

Dear Pieter,

I have reread a number of contributions to LML of Joel Almeida. Sometimes his contributions are confronting for some. But there is one thing I think he wants to explain. That is the way we handle our patients at present is not leading to less infections in endemic areas in the future.


I fully agree with him that that post exposure prophylaxis is not enough for downgrading and lepromatous patients and that certainly polar lepromatous patients should be treated for life. For BL and subpolar lepromatous patients who are downgraded till they started treatment. However, treatment of only 1 year is not enough. Because they will either be reinfected or have a relapse. They should be treated for, let's say the number of years their BI is at diagnosis. Thereafter their CMI should be increased by vaccination. Not once but repeatedly, the interval should be researched.  This is not like in most PEP research, only a follow up for a few years. But a lifelong follow up. Then they will not spread bacilli after so-called being cured.

 

Ben


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion visit https://groups.google.com/d/msgid/leprosymailinglist/77b47dbe-da29-48cb-911c-ec8e86b5544dn%40googlegroups.com.

No comments: